Clinical Edge Journal Scan

COVID-19-related pulmonary sequelae common in patients with diabetes


 

Key clinical point : Pulmonary sequelae at 6 months after COVID-19 infection are more common in patients with diabetes or hyperglycemia compared with normoglycemic individuals.

Major finding: At 6 months, residual lung abnormalities on computed tomography were seen in 65.4%, 58.3%, and 36.6% of patients with preexisting diabetes, secondary hyperglycemia, and normoglycemia, respectively.

Study details: The data come from a retrospective study of 141 patients with COVID-19 at 2 hospitals in Wuhan, China.

Disclosures: The research was supported by the National Natural Science Foundation of China, National Key Research and Development Project of China, and Zhejiang University. The authors declared no competing interests.

Source: Li Y et al. Eur J Radiol. 2021 Oct 5. doi: 10.1016/j.ejrad.2021.109997 .

Recommended Reading

COVID-19: Early administration of plasma fails to prevent disease progression
Covid ICYMI
COVID-19: Pulmonary embolism not tied to increased mortality risk
Covid ICYMI
COVID-19: Inhaled budesonide may shorten recovery time
Covid ICYMI
Canakinumab fails to improve survival in hospitalized patients with severe COVID-19
Covid ICYMI
Hospitalized COVID-19 patients with cardiometabolic risk do not benefit from dapagliflozin
Covid ICYMI
COVID-19: Antibody cocktail effective in preventing household transmission
Covid ICYMI
Mortality-related risk factors for hospitalized patients with COVID-19
Covid ICYMI
Clinical Edge Journal Scan Commentary: COVID-19 October 2021
Covid ICYMI
Substance abuse boosts COVID hospitalization, death risk, even after vaccination
Covid ICYMI
Few JAK inhibitor users have diminished immune response to COVID-19 vaccines
Covid ICYMI